Clinical Trials Browser

Phase 2 × NIH × sulindac sulfone × Clear all

NCT00078910 2013-06-24

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms